PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.\', \'Department of Biostatistics, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.\', \'Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.\', \'Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.\', \'W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.\', \'Bloomberg Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/cid/ciab376
?:doi
?:hasPublicationType
?:journal
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
is ?:pmid of
?:pmid
?:pmid
  • 34013339
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Differential Cytokine Signatures of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Influenza Infection Highlight Key Differences in Pathobiology.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all